AWHLAspira Women's Health Inc.

About Aspira Women's Health Inc. (AWHL)

Aspira Women's Health Inc. (AWHL) is a Diagnostics & Research company headquartered in Austin, TX, United States whose shares trade over-the-counter on the OTCQB tier.

Aspira Women's Health is helping transform women's health with the discovery, development, and utilization of innovative testing options and bio-analytical solutions that help physicians assess risk, optimize patient management and improve gynecologic health outcomes for women.

Products and services

(1) the Ova1Plus workflow, which uses Ova1, a qualitative serum test intended as an aid to further assess the likelihood of malignancy in women with an ovarian adnexal mass for which surgery is planned when the physician’s independent clinical and radiological evaluation does not indicate malignancy, as the primary test and Overa, a second-generation biomarker test, as a reflex for Ova1 intermediate range results; and (2) OvaWatch, a lab developed test intended to assist in the initial clinical assessment of malignancy risk in all women thought to have an indeterminate or benign adnexal mass. Collectively, these tests are referred to and marketed as OvaSuite.

AWHL key facts

Ticker symbol

AWHL

Market tier

OTCQB

Sector

Healthcare

Industry

Diagnostics & Research

Headquarters

Austin, TX, United States

Country of incorporation

US

Year of incorporation

1993

Employees

43

Estimated market cap

$1.90M (as of May 6, 2025)

Shares outstanding

30,153,924

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

12/31

Aspira Women's Health Inc. leadership

• Michael Buhle — CEO
• Julie Carrillo — Controller

Explore more: Diagnostics & Research stocks · Healthcare sector · OTCQB stocks · OTC stocks starting with A